FR2957803B1 - Diluants adjuvants de vaccins vivants pour maladies porcines - Google Patents
Diluants adjuvants de vaccins vivants pour maladies porcinesInfo
- Publication number
- FR2957803B1 FR2957803B1 FR1052114A FR1052114A FR2957803B1 FR 2957803 B1 FR2957803 B1 FR 2957803B1 FR 1052114 A FR1052114 A FR 1052114A FR 1052114 A FR1052114 A FR 1052114A FR 2957803 B1 FR2957803 B1 FR 2957803B1
- Authority
- FR
- France
- Prior art keywords
- water
- adjuvant
- oil
- live vaccines
- swine diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000002671 adjuvant Substances 0.000 title abstract 3
- 239000003085 diluting agent Substances 0.000 title abstract 3
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 208000012153 swine disease Diseases 0.000 title 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 abstract 1
- 208000005342 Porcine Reproductive and Respiratory Syndrome Diseases 0.000 abstract 1
- 239000000150 Sympathomimetic Substances 0.000 abstract 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 229910001628 calcium chloride Inorganic materials 0.000 abstract 1
- 239000001110 calcium chloride Substances 0.000 abstract 1
- HSJPMRKMPBAUAU-UHFFFAOYSA-N cerium(3+);trinitrate Chemical compound [Ce+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O HSJPMRKMPBAUAU-UHFFFAOYSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000000839 emulsion Substances 0.000 abstract 1
- 229910017053 inorganic salt Inorganic materials 0.000 abstract 1
- 235000014413 iron hydroxide Nutrition 0.000 abstract 1
- NCNCGGDMXMBVIA-UHFFFAOYSA-L iron(ii) hydroxide Chemical compound [OH-].[OH-].[Fe+2] NCNCGGDMXMBVIA-UHFFFAOYSA-L 0.000 abstract 1
- 229910052751 metal Inorganic materials 0.000 abstract 1
- 239000002184 metal Substances 0.000 abstract 1
- 150000002739 metals Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000004530 micro-emulsion Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000001850 reproductive effect Effects 0.000 abstract 1
- 230000000241 respiratory effect Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000001975 sympathomimetic effect Effects 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 abstract 1
- 229960001763 zinc sulfate Drugs 0.000 abstract 1
- 229910000368 zinc sulfate Inorganic materials 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/10011—Arteriviridae
- C12N2770/10051—Methods of production or purification of viral material
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Abstract
Procédé de préparation d'une composition vaccinale injectable destinée à combattre le syndrome dysgénésique et respiratoire (SDRP) chez les espèces porcines comprenant au moins l'étape : a) mélange d'un vaccin vivant extemporanément avec un diluant adjuvant (DA) ; caractérisé en ce que ledit diluant adjuvant est une émulsion de type huile dans eau ou une microémulsion de type huile dans eau, ou une solution aqueuse comprenant de l'eau et au moins un sel minéral choisi parmi l'hydroxyde d'aluminium, le nitrate de cérium, le sulfate de zinc, l'hydroxyde de fer colloïdal ou le chlorure de calcium les sels de métaux divalents ou trivalents ou encore de composés sympathomimétiques.
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1052114A FR2957803B1 (fr) | 2010-03-24 | 2010-03-24 | Diluants adjuvants de vaccins vivants pour maladies porcines |
EP11713006A EP2550016A2 (fr) | 2010-03-24 | 2011-03-15 | Diluants adjuvants de vaccins vivants pour maladies porcines |
BR112012024154A BR112012024154A2 (pt) | 2010-03-24 | 2011-03-15 | diluentes adjuvantes para vacinas vivas para doenças de porcos |
PCT/FR2011/050514 WO2011117506A2 (fr) | 2010-03-24 | 2011-03-15 | Diluants adjuvants de vaccins vivants pour maladies porcines |
MX2012010851A MX342238B (es) | 2010-03-24 | 2011-03-15 | Diluyentes adyuvantes para vacunas atenuadas para enfermedades porcinas. |
RU2012145084/15A RU2557968C2 (ru) | 2010-03-24 | 2011-03-15 | Адъюванты-разбавители для живых вакцин от болезней свиней |
US13/636,741 US20130011434A1 (en) | 2010-03-24 | 2011-03-15 | Adjuvant diluents for live vaccines for pig diseases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1052114A FR2957803B1 (fr) | 2010-03-24 | 2010-03-24 | Diluants adjuvants de vaccins vivants pour maladies porcines |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2957803A1 FR2957803A1 (fr) | 2011-09-30 |
FR2957803B1 true FR2957803B1 (fr) | 2012-06-01 |
Family
ID=42635539
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR1052114A Active FR2957803B1 (fr) | 2010-03-24 | 2010-03-24 | Diluants adjuvants de vaccins vivants pour maladies porcines |
Country Status (7)
Country | Link |
---|---|
US (1) | US20130011434A1 (fr) |
EP (1) | EP2550016A2 (fr) |
BR (1) | BR112012024154A2 (fr) |
FR (1) | FR2957803B1 (fr) |
MX (1) | MX342238B (fr) |
RU (1) | RU2557968C2 (fr) |
WO (1) | WO2011117506A2 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103059073A (zh) * | 2012-12-14 | 2013-04-24 | 江苏省海安石油化工厂 | 失水甘露醇油酸酯的制备方法 |
FR3012964A1 (fr) * | 2013-11-12 | 2015-05-15 | Seppic Sa | Vaccins adjuves pour vaccination aviaire in ovo |
EA202090768A1 (ru) * | 2018-05-04 | 2020-06-11 | Борис Славинович ФАРБЕР | Вакцины с повышенной иммуногенностью, низкой аллергенностью и реактогенностью |
CN110665000B (zh) * | 2018-07-02 | 2022-11-11 | 厦门大学 | 锌铝复合佐剂的制备及作为疫苗佐剂的用途 |
FR3107454B1 (fr) * | 2020-02-20 | 2023-02-10 | Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic | Adjuvant de vaccin comprenant un microlatex inverse |
CN113371753A (zh) * | 2021-06-07 | 2021-09-10 | 江苏农林职业技术学院 | 一种纳米锌及其绿色合成方法和应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL8301996A (nl) * | 1983-06-06 | 1985-01-02 | Duphar Int Res | Werkwijze ter bereiding van geadjuveerde levende vaccins en aldus verkregen geadjuveerde levende vaccins. |
US6676958B2 (en) * | 2001-06-19 | 2004-01-13 | Advanced Bioadjuvants, Llc | Adjuvant composition for mucosal and injection delivered vaccines |
PL1613346T3 (pl) * | 2003-04-04 | 2013-03-29 | Zoetis Services Llc | Poddane mikrofluidyzacji emulsje typu olej w wodzie i kompozycje szczepionek |
EP1651265B1 (fr) * | 2003-07-24 | 2008-04-23 | Merial Limited | Formulation vaccinale comportant une émulsion d'huile en eau |
RU2269361C2 (ru) * | 2004-03-25 | 2006-02-10 | Федеральное государственное учреждение "Федеральный центр охраны здоровья животных" (ФГУ ВНИИЗЖ) | Вакцина ассоциированная эмульсионная инактивированная против репродуктивно-респираторного синдрома и парвовирусной инфекции свиней |
WO2006074986A2 (fr) * | 2005-01-13 | 2006-07-20 | Boehringer Ingelheim Vetmedica Gmbh | Vaccins ameliores contre le srrp |
RU2510280C2 (ru) * | 2008-06-27 | 2014-03-27 | Пфайзер Инк. | Новые адъювантные композиции |
-
2010
- 2010-03-24 FR FR1052114A patent/FR2957803B1/fr active Active
-
2011
- 2011-03-15 WO PCT/FR2011/050514 patent/WO2011117506A2/fr active Application Filing
- 2011-03-15 US US13/636,741 patent/US20130011434A1/en not_active Abandoned
- 2011-03-15 MX MX2012010851A patent/MX342238B/es active IP Right Grant
- 2011-03-15 RU RU2012145084/15A patent/RU2557968C2/ru active
- 2011-03-15 EP EP11713006A patent/EP2550016A2/fr not_active Withdrawn
- 2011-03-15 BR BR112012024154A patent/BR112012024154A2/pt not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
RU2012145084A (ru) | 2014-04-27 |
FR2957803A1 (fr) | 2011-09-30 |
EP2550016A2 (fr) | 2013-01-30 |
RU2557968C2 (ru) | 2015-07-27 |
US20130011434A1 (en) | 2013-01-10 |
WO2011117506A2 (fr) | 2011-09-29 |
WO2011117506A3 (fr) | 2011-11-17 |
BR112012024154A2 (pt) | 2016-06-28 |
MX342238B (es) | 2016-09-21 |
MX2012010851A (es) | 2013-04-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2957803B1 (fr) | Diluants adjuvants de vaccins vivants pour maladies porcines | |
CR20220609A (es) | Antagonistas del receptor de lpa y usos de los mismos | |
JP2020507589A5 (fr) | ||
EA200901161A1 (ru) | Вакцина против гриппа в виде эмульсии типа "масло в воде" | |
WO2008136019A3 (fr) | Procédé pour la préparation d'une silice précipitée finement divisée | |
JP2011140525A5 (fr) | ||
AR043531A1 (es) | Procedimiento para la preparacion de n-(3, 5-dicloropidid-4-il)-3-ciclopropilmetoxi-4-difluorometoxibenzamida (inn: roflumilast) | |
JP2012502064A5 (fr) | ||
WO2007052155A3 (fr) | Vaccins antigrippaux presentant un taux reduit d'adjuvants de type emulsion | |
BR112015000475A2 (pt) | métodos de indução de anestesia | |
JP2016530285A5 (fr) | ||
JP2017514910A5 (fr) | ||
BRPI0813309B8 (pt) | capsídeo, mistura de capsídeos e proteína quimérica | |
TN2015000356A1 (en) | Bicyclic compounds | |
BR112018011331A2 (pt) | mutante de proteìna l1 de papillomavirus humano tipo 11 | |
JP2013517224A5 (fr) | ||
HRP20201187T1 (hr) | Derivat triazolopirazinona koristan kao inhibitor ljudskog pde1 | |
BR112014004261A2 (pt) | diagnósticos de vacina melhorada | |
BR112017008709A2 (pt) | tratamento ou prevenção da anemia em mamíferos não-humanos grávidos | |
HRP20201952T1 (hr) | Mješovite soli hidroksi-alkanske sulfinske kiseline | |
RU2012145081A (ru) | Живая вакцина против заболеваний птиц | |
BR112018001005A2 (pt) | Fluido terapêutico peritoneal, recipiente ou kit do mesmo | |
EP3593650A3 (fr) | Préparations pour l`augmentation du ph dans un aliment par la génération d`hydrogène moléculaire | |
CN105396131A (zh) | 一种用于呼肠孤灭活疫苗的佐剂及其制备方法 | |
Barraclough et al. | Hepatitis B virus infection in hemodialysis populations: progress toward prevention |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 7 |
|
PLFP | Fee payment |
Year of fee payment: 8 |
|
PLFP | Fee payment |
Year of fee payment: 9 |
|
PLFP | Fee payment |
Year of fee payment: 11 |
|
PLFP | Fee payment |
Year of fee payment: 12 |
|
PLFP | Fee payment |
Year of fee payment: 13 |
|
PLFP | Fee payment |
Year of fee payment: 14 |
|
PLFP | Fee payment |
Year of fee payment: 15 |